Search results for "skeletal muscle"

showing 10 items of 430 documents

Characteristic morphologic manifestation of CADASIL, cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, in s…

1997

Pathologymedicine.medical_specialtyPhysiologyLeukoencephalopathyCellular and Molecular NeurosciencePhysiology (medical)medicineHumansCADASILMuscle SkeletalSkinbusiness.industryVascular diseaseLeukoencephalopathy Progressive MultifocalSkeletal muscleAnatomyCerebral InfarctionCADASIL SyndromeMiddle Agedmedicine.diseaseIntracranial ArteriosclerosisMicroscopy Electronmedicine.anatomical_structureFemaleNeurology (clinical)ComplicationbusinessMusclenerve
researchProduct

The nature of host tissue destruction in tumor invasion

1986

The nature of host tissue destruction in tumor invasion was investigated in experimentally induced carcinomas and sarcomas, xenografted into skeletal muscle. By means of light and electron microscopy it was shown that in both carcinomas and sarcomas the confrontation of host tissue with the invading tumor cells does not result in immediate destruction of host tissue but in a transitory state of coexistence which gradually proceeds to progressive host tissue atrophy. This process of progressive atrophy, which finally results in the total disappearance of the invaded host tissue, is considered to be caused mainly by the increasing pressure and competitive withdrawal of oxygen and nutrients by…

Pathologymedicine.medical_specialtyRatónTransplantation HeterologousMice NudeAdenocarcinomaBiologyHost tissueExtracellular matrixMiceAtrophymedicineCarcinomaAnimalsNeoplasm InvasivenessProcess (anatomy)MusclesSkeletal musclemedicine.diseaseRatsMicroscopy ElectronMuscular Atrophymedicine.anatomical_structureRats Inbred LewSarcoma ExperimentalSarcomaNeoplasm TransplantationVirchows Archiv B Cell Pathology Including Molecular Pathology
researchProduct

Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A

1988

1. 1. We have investigated the kinetics of inhibition of cathepsin D in heart, liver and skeletal muscle of CD-1 mice following administration of 25, 50, 100 and 200 mg/kg i.p. of pepstatin A, a specific inhibitor of this protease. 2. 2. In the liver, a significant inhibition of cathepsin D occurred up to at least 15 days, whereas, in heart and skeletal muscle, this inhibition lasted for a much shorter period of time. 3. 3. These results show that the recovery of enzyme activity to normal values is dose-dependent and that, at the same dose level, marked differences occur in the recovery of enzyme activity in these organ tissues, the liver being the most sensitive one. © 1988.

Pepstatin Amedicine.medical_treatmentPeriod (gene)KineticsCathepsin DBiochemistryCathepsin DMicechemistry.chemical_compoundIn vivoPepstatinsmedicineAnimalsProteasebiologyMusclesMyocardiumSkeletal muscleEnzyme assayKineticsmedicine.anatomical_structureLiverchemistryBiochemistrybiology.proteinFemaleProteinase InhibitorsOligopeptidesPepstatin
researchProduct

Extracellular ATP Increases <i>L</i>-Carnitine Transport and Content in C2C12 Cells

2008

Extracellular ATP regulates cell proliferation, muscle contraction and myoblast differentiation. ATP present in the muscle interstitium can be released from contracting skeletal muscle cells. <i>L</i>-Carnitine is a key element in muscle cell metabolism, as it serves as a carrier for fatty acid through mitochondrial membranes, controlling oxidation and energy production. Treatment of C2C12 cells with 1 mmol/l of ATP induced a marked increase in <i>L</i>-carnitine uptake that was associated with an increase in <i>L</i>-carnitine content in these cells. These effects were found to be dependent on the density of the cultured cells and on the dose of ATP. The…

PharmacologyP2Y receptorChemistrySkeletal muscleGeneral MedicineMetabolismCell biologymedicine.anatomical_structureBiochemistrymedicineExtracellularMyocytemedicine.symptomITGA7ActinMuscle contractionPharmacology
researchProduct

Beneficial effects of l-carnitine in myoblastic C2C12 cells

2003

L-Carnitine is a key molecule in the transfer of fatty acid across mitochondrial membranes. Bioavailable L-carnitine is either provided by an endogeneous biosynthesis or after intestinal absorption of dietary items containing L-carnitine. After intestinal absorption or hepatic biosynthesis, L-carnitine is transferred to organs whose metabolism is dependent upon fatty acid oxidation, such as skeletal muscle. To cross the muscle plasma membrane, there are several transporters involved. Among those transporters, OCTN2 is actually the only one to have been clearly characterized. Zidovudine is a commonly used inhibitor of human immunodeficiency virus (HIV) replication. Zidovudine has many side e…

PharmacologySkeletal muscleBiologyMitochondrionPharmacologyBiochemistryIntestinal absorptionZidovudinemedicine.anatomical_structureBiochemistrymedicineMyocyteCarnitinemedicine.symptomMyopathyBeta oxidationmedicine.drugBiochemical Pharmacology
researchProduct

The metalloproteinase-disintegrin ADAM10 is exclusively expressed by type I muscle fibers.

2008

ADAM10 (Kuzbanian) is a member of a recently discovered family of membrane-anchored metalloproteinases with a complex and conserved domain structure. In part, these metalloproteinases have been implicated in muscle formation. Herein the expression pattern of ADAM10 in human skeletal muscle was studied. ADAM10 was found to be present in human myoblasts and to be exclusively expressed in type I fibers, suggesting that it may be critical in muscle fiber differentiation.

PhysiologyADAM10Matrix metalloproteinaseCellular and Molecular NeuroscienceADAM10 ProteinPhysiology (medical)DisintegrinmedicineMyocyteHumansAdenosine TriphosphatasesMetalloproteinasebiologyMyosin Heavy ChainsMyogenesisChemistrySkeletal muscleMembrane ProteinsCell biologyADAM Proteinsmedicine.anatomical_structureMuscle Fibers Slow-TwitchBiochemistrybiology.proteinNeurology (clinical)Amyloid Precursor Protein SecretasesITGA7Musclenerve
researchProduct

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase from frog skeletal muscle: purification, kinetics and immunological properties.

1993

Fructose 2,6-bisphosphate is the most potent activator of 6-phosphofructo-1-kinase, a key regulatory enzyme of glycolysis in animal tissues. This study was prompted by the finding that the content of fructose 2,6-bisphosphate in frog skeletal muscle was dramatically increased at the initiation of exercise and was closely correlated with the glycolytic flux during exercise. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, the enzyme system catalyzing the synthesis and degradation of fructose 2,6-bisphosphate, was purified from frog (Rana esculenta) skeletal muscle and its properties were compared with those of the rat muscle type enzyme expressed in Escherichia coli using recombinant DN…

PhysiologyPhosphofructokinase-2BiologyBiochemistrychemistry.chemical_compoundEndocrinologymedicineFructosediphosphatesAnimalsGlycolysisPhosphorylationEcology Evolution Behavior and Systematicschemistry.chemical_classificationMolecular massImmunochemistryMusclesPhosphotransferasesSkeletal muscleRana esculentaFructoseHydrogen-Ion ConcentrationMolecular WeightKineticsmedicine.anatomical_structureEnzymechemistryFructose 26-bisphosphateBiochemistryGRENOUILLEAnimal Science and ZoologyPhosphoenolpyruvate carboxykinaseProtein KinasesJournal of comparative physiology. B, Biochemical, systemic, and environmental physiology
researchProduct

De Novo prion aggregates trigger autophagy in skeletal muscle

2014

ABSTRACT In certain sporadic, familial, and infectious prion diseases, the prion protein misfolds and aggregates in skeletal muscle in addition to the brain and spinal cord. In myocytes, prion aggregates accumulate intracellularly, yet little is known about clearance pathways. Here we investigated the clearance of prion aggregates in muscle of transgenic mice that develop prion disease de novo . In addition to neurodegeneration, aged mice developed a degenerative myopathy, with scattered myocytes containing ubiquitinated, intracellular prion inclusions that were adjacent to myocytes lacking inclusions. Myocytes also showed elevated levels of the endoplasmic reticulum chaperone Grp78/BiP, su…

PrionsAutophagosome maturationanimal diseasesBlotting WesternImmunologyMice TransgenicBiologyProtein degradationPolymerase Chain ReactionMedical and Health SciencesMicrobiologyTransgenicPrion DiseasesMiceVirologyAutophagymedicineAnimalsMyocyteMuscle SkeletalEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsDNA PrimersMuscle CellsAgricultural and Veterinary SciencesBlottingEndoplasmic reticulumNeurodegenerationAutophagySkeletal muscleSkeletalBiological Sciencesmedicine.diseaseImmunohistochemistryMolecular biologynervous system diseasesmedicine.anatomical_structureInsect ScienceChaperone (protein)biology.proteinMuscleWestern
researchProduct

Label-free profiling of skeletal muscle using high-definition mass spectrometry

2014

We report automated and time efficient (2 h per sample) profiling of muscle using ultra-performance liquid chromatography (LC) coupled directly with high-definition mass spectrometry (HDMSE). Soluble proteins extracted from rat gastrocnemius (n=10) were digested with trypsin and analysed in duplicate using a 90 min RPLC gradient. Protein identification and label-free quantitation were performed from HDMSE spectra analysed using TransOmics Informatics for Proteomics software. In total 1,514 proteins were identified. Of these, 811 had at least 3 unique peptides and were subsequently used to assess the dynamic range and precision of LC-HDMSE label-free profiling. Proteins analysed by LC-HDMSE …

ProteomicsMuscle Proteinsta3111ProteomicsMass spectrometryBiochemistryArticleMass Spectrometryion mobilityLiquid chromatography–mass spectrometryanimal proteomicsdata-independent acquisitionmedicineAnimalsData-independent acquisitionMuscle Skeletalta315Molecular Biologychemistry.chemical_classificationChromatographyta1184Skeletal muscleTricarboxylic acidTrypsinRatsLC-MSEnzymemedicine.anatomical_structurechemistryBiochemistryChromatography Liquidmedicine.drugPROTEOMICS
researchProduct

Alveolar gas exchange and tissue deoxygenation during exercise in type 1 diabetes patients and healthy controls.

2012

We used near-infrared spectroscopy to investigate whether leg and arm skeletal muscle and cerebral deoxygenation differ during incremental cycling exercise in men with type 1 diabetes (T1D, n=10, mean±SD age 33±7 years) and healthy control men (matched by age, anthrometry, and self-reported physical activity, CON, n=10, 32±7 years) to seek an explanation for lower aerobic capacity (˙VO2peak) often reported in T1D. T1D had lower ˙VO2peak (35±4mlkg(-1)min(-1) vs. 43±8mlkg(-1)min(-1), P0.01) and peak work rate (219±33W vs. 290±44W, P0.001) than CON. Leg muscle deoxygenation (↑ [deoxyhemoglobin]; ↓ tissue saturation index) was greater in T1D than CON at a given absolute submaximal work rate, bu…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyendocrine system diseasesPhysiologyMatched-Pair AnalysisPhysical activity030209 endocrinology & metabolism030204 cardiovascular system & hematology03 medical and health sciencesHemoglobins0302 clinical medicineOxygen ConsumptionReference ValuesInternal medicineHealthy controlmedicineHumansMuscle SkeletalDeoxygenationExerciseAerobic capacityType 1 diabetesSpectroscopy Near-InfraredChemistryPulmonary Gas ExchangeGeneral NeuroscienceSkeletal muscleGas exchangemedicine.diseaseAdaptation PhysiologicalSurgeryFrontal LobePulmonary Alveolimedicine.anatomical_structureDiabetes Mellitus Type 1Case-Control StudiesCardiologyExercise TestRespiratory physiologyneurobiology
researchProduct